Literature DB >> 20194033

Interleukin-22 is a negative regulator of the allergic response.

Bruno Schnyder1, Carla Lima, Silvia Schnyder-Candrian.   

Abstract

A proinflammatory role of T helper (Th)17 cells, producing IL-22 and IL-17A, has been favored although there is evidence for negative immune regulation by IL-17A. Here we show that IL-22 was produced during an allergic response in lungs of mice, immunized and challenged with ovalbumin (OVA), and that IL-22 neutralization further augmented the eosinophil recruitment to the lung. In a second allergy model, transfer of OVA-pulsed dendritic cells (DC) into naive mice conveyed eosinophil recruitment in response to subsequent inhaled OVA challenge, while DC preincubation with recombinant IL-22 abolished this response. Similarly, DC preincubation with IL-17A abolished DC-driven eosinophil recruitment, showing that both Th17 cytokines IL-22 and IL-17A mediate negative regulation of allergy by acting on DCs. Therefore, IL-22 inhibits DC functions and attenuates an allergic response. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194033     DOI: 10.1016/j.cyto.2010.02.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  23 in total

1.  The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A.

Authors:  Ana Paula Moreira; Karen A Cavassani; Ugur B Ismailoglu; Rikki Hullinger; Michael P Dunleavy; Darryl A Knight; Steven L Kunkel; Satoshi Uematsu; Shizuo Akira; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 2.  Innate lymphoid cells--how did we miss them?

Authors:  Jennifer A Walker; Jillian L Barlow; Andrew N J McKenzie
Journal:  Nat Rev Immunol       Date:  2013-01-07       Impact factor: 53.106

Review 3.  Interleukin-22: a likely target for treatment of autoimmune diseases.

Authors:  Xuyan Yang; Song Guo Zheng
Journal:  Autoimmun Rev       Date:  2014-01-10       Impact factor: 9.754

4.  A critical role for donor-derived IL-22 in cutaneous chronic GVHD.

Authors:  Kate H Gartlan; Hemamalini Bommiasamy; Katelyn Paz; Andrew N Wilkinson; Mary Owen; Dawn K Reichenbach; Tatjana Banovic; Kimberly Wehner; Faith Buchanan; Antiopi Varelias; Rachel D Kuns; Karshing Chang; Yuri Fedoriw; Thomas Shea; James Coghill; Michael Zaiken; Maximilian W Plank; Paul S Foster; Andrew D Clouston; Bruce R Blazar; Jonathan S Serody; Geoffrey R Hill
Journal:  Am J Transplant       Date:  2017-10-24       Impact factor: 8.086

5.  Diagnostic value of interleukin 22 and carcinoembryonic antigen in tuberculous and malignant pleural effusions.

Authors:  DI Jin; Ying Chen; Zhengyun Wang; Siwei Wang; Hansvin Bunjhoo; Jing Zhu; Yong Cao; Weining Xiong; Shengdao Xiong; Yongjian Xu; Huijuan Fang
Journal:  Exp Ther Med       Date:  2011-08-25       Impact factor: 2.447

6.  Expression of interleukin-22 and its significance in the pathogenesis of chronic rhinosinusitis.

Authors:  Xin Wang; Mi Gao; Yuan Xu; Huamin Guo; Chunyuan Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 7.  Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease.

Authors:  Kiyoshi Hirahara; Amanda Poholek; Golnaz Vahedi; Arian Laurence; Yuka Kanno; Joshua D Milner; John J O'Shea
Journal:  J Allergy Clin Immunol       Date:  2013-05       Impact factor: 10.793

Review 8.  [Immune system and allergies-An unholy alliance].

Authors:  Ludger Klimek
Journal:  Internist (Berl)       Date:  2022-04-07       Impact factor: 0.743

9.  IL-22 promotes allergic airway inflammation in epicutaneously sensitized mice.

Authors:  Juan Manuel Leyva-Castillo; Juhan Yoon; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2018-06-18       Impact factor: 10.793

10.  Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.

Authors:  Lin-lin Shao; Lei Zhang; Yu Hou; Shuang Yu; Xin-guang Liu; Xiao-yang Huang; Yuan-xin Sun; Tian Tian; Na He; Dao-xin Ma; Jun Peng; Ming Hou
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.